nChroma Bio is a Biotech company based in Boston, Massachusetts. It has raised $75M in total funding. Latest round: Series B.
nChroma Bio funding overview
nChroma Bio is a Biotech company based in Boston, Massachusetts. nChroma Bio has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2024. The round record for nChroma Bio runs through 2024; nothing later has been disclosed. Investors on record include Cormorant Asset Management, ARCH Venture Partners, Atlas Venture, Newpath Partners, 5AM Ventures, DCVC Bio and 13 others. 19 distinct backers are named across the disclosed rounds.
nChroma Bio has raised $75M in total disclosed funding across the rounds on record.
Who has invested in nChroma Bio?
Cormorant Asset Management, ARCH Venture Partners, Atlas Venture, Newpath Partners, 5AM Ventures, DCVC Bio are named among the investors backing nChroma Bio.
What was the latest nChroma Bio funding round?
The most recent disclosed round is a Series B, announced in December 2024.
Where is nChroma Bio based?
nChroma Bio is based in Boston, Massachusetts.
What sector does nChroma Bio operate in?
nChroma Bio is tracked under Biotech from Boston, Massachusetts, with $75M in disclosed funding.
When did nChroma Bio last raise?
The last disclosed nChroma Bio round closed in December 2024 at Series B.
Totals shown for nChroma Bio aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
